Molecular basis of non-syndromic hypospadias: systematic mutation screening and genome-wide copy-number analysis of 62 patients.

Abstract

STUDY QUESTION:

What percentage of cases with non-syndromic hypospadias can be ascribed to mutations in known causative/candidate/susceptibility genes or submicroscopic copy-number variations (CNVs) in the genome?

SUMMARY ANSWER:

Monogenic and digenic mutations in known causative genes and cryptic CNVs account for >10% of cases with non-syndromic hypospadias. While known susceptibility polymorphisms appear to play a minor role in the development of this condition, further studies are required to validate this observation.

WHAT IS KNOWN ALREADY:

Fifteen causative, three candidate, and 14 susceptible genes, and a few submicroscopic CNVs have been implicated in non-syndromic hypospadias.

STUDY DESIGN, SIZE, DURATION:

Systematic mutation screening and genome-wide copy-number analysis of 62 patients.

PARTICIPANTS/MATERIALS, SETTING, METHODS:

The study group consisted of 57 Japanese and five Vietnamese patients with non-syndromic hypospadias. Systematic mutation screening was performed for 25 known causative/candidate/susceptibility genes using a next-generation sequencer. Functional consequences of nucleotide alterations were assessed by in silico assays. The frequencies of polymorphisms in the patient group were compared with those in the male general population. CNVs were analyzed by array-based comparative genomic hybridization and characterized by fluorescence in situ hybridization.

MAIN RESULTS AND THE ROLE OF CHANCE:

Seven of 62 patients with anterior or posterior hypospadias carried putative pathogenic mutations, such as hemizygous mutations in AR, a heterozygous mutation in BNC2, and homozygous mutations in SRD5A2 and HSD3B2. Two of the seven patients had mutations in multiple genes. We did not find any rare polymorphisms that were abundant specifically in the patient group. One patient carried mosaic dicentric Y chromosome.

LIMITATIONS, REASONS FOR CAUTION:

The patient group consisted solely of Japanese and Vietnamese individuals and clinical and hormonal information of the patients remained rather fragmentary. In addition, mutation analysis focused on protein-altering substitutions.

WIDER IMPLICATIONS OF THE FINDINGS:

Our data provide evidence that pathogenic mutations can underlie both mild and severe hypospadias and that HSD3B2 mutations cause non-syndromic hypospadias as a sole clinical manifestation. Most importantly, this is the first report documenting possible oligogenicity of non-syndromic hypospadias.

STUDY FUNDING/COMPETING INTERESTS:

This study was funded by the Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology; by the Grant-in-Aid from the Japan Society for the Promotion of Science; by the Grants from the Ministry of Health, Labour and Welfare, from the National Center for Child Health and Development and from the Takeda Foundation. The authors have no competing interests to disclose.

TRIAL REGISTRATION NUMBER:

Not applicable.

• Authors: M Kon, E Suzuki, V C Dung, Y Hasegawa, T Mitsui, K Muroya, K Ueoka, N Igarashi, K Nagasaki, Y Oto, T Hamajima, K Yoshino, M Igarashi, Y Kato-Fukui, K Nakabayashi, K Hayashi, K Hata, Y Matsubara, K Moriya, T Ogata, K Nonomura, M Fukami
• Journal: Human reproduction (Oxford, England) (Hum Reprod) Vol. 30 Issue 3 Pg. 499-506 (Mar 2015) ISSN: 1460-2350 [Electronic] England
• PMID: 25605705 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: [email protected].

Topics

• DNA Copy Number Variations
• DNA Mutational Analysis
• Genetic Predisposition to Disease
• Humans
• Hypospadias (genetics)
• Male
• Polymorphism, Genetic